Workflow
解码创新“生力军”的韧性生长,2025“未来20”全国企业成长力调研加速推进
Di Yi Cai Jing·2025-08-25 05:41

Core Insights - The health of small and medium-sized enterprises (SMEs) is crucial for the improvement of industrial structure and the release of innovative vitality in China's economy [1] - The "NEXT20" initiative aims to evaluate the growth potential of small-cap listed companies in the A-share market, filling a gap in the research and tracking of these companies [1] - A total of 68 companies have been shortlisted for the second phase of research after a rigorous evaluation process [1] Group 1 - The project evaluation team has begun on-site visits to shortlisted companies, including those in the semiconductor and power equipment industries, as well as advanced medical device firms with high R&D capabilities [2] - During these visits, the evaluation team gained insights into the core competitive advantages and underlying business logic of these SMEs, witnessing their efforts in promoting innovative technology applications and stable industrial growth [2][4] - Company managers shared key milestones in their development and demonstrated their confidence in sustaining market and customer interest in their products [4] Group 2 - Many technology innovation companies are expanding their markets through overseas operations, with the evaluation team learning about their experiences in global business management [7] - Companies displayed a rational assessment of risks and returns in complex overseas markets, along with a clear understanding of their growth objectives [7] - The evaluation team plans to continue in-depth assessments of shortlisted companies across various cities, aiming to identify those with sustainable innovation potential and strong commercialization capabilities [9] Group 3 - The "NEXT20" list will be unveiled in November, with a forum and award ceremony in Shanghai, inviting government leaders, experts, and representatives from various sectors to discuss the cultivation of new productive forces [9]